Stock A348150 KOBIOLABS, INC
Add to a list
To use this feature you must be a member
Log inSign up

All News KoBioLabs, Inc

Equities

A348150

KR7348150004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
8,370 KRW +13.88% Intraday chart for KoBioLabs, Inc +5.55% -1.65%
2022 5,607,000 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2022. CI
2022 KoBioLabs, Inc announced that it has received KRW 10.000016 billion in funding from E-MART Inc. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
5,607,000 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2022.
CI
KoBioLabs, Inc announced that it has received KRW 10.000016 billion in funding from E-MART Inc.
CI
KoBioLabs to Raise $8 Million via Stock Offering
MT
KoBioLabs, Inc announced that it expects to receive KRW 10.000016 billion in funding from E-MART Inc.
CI
KoBioLabs, Inc announced that it has received KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors
CI
KoBioLabs, Inc announced that it has received KRW 4.64999775 billion in funding
CI
KoBioLabs, Inc announced that it expects to receive KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors
CI
KoBioLabs, Inc announced that it has received KRW 44.4498035 billion in funding from Jaedam Inc., Cornerstone Investment Partners Co., Ltd. and other investors
CI
1,130,196 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2021.
CI
Kobiolabs Targets Over $28 Million Through Stock Offering
MT
KoBioLabs, Inc announced that it expects to receive KRW 44.4498035 billion in funding from Jaedam Inc., Cornerstone Investment Partners Co., Ltd. and other investors
CI
KoBioLabs, Inc(KOSDAQ:A348150) added to S&P Global BMI Index
CI
213,600 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-MAY-2021.
CI
840,158 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-FEB-2021.
CI
845,970 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-JAN-2021.
CI
2,525,978 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-DEC-2020.
CI
KoBioLabs,Inc has completed an IPO in the amount of KRW 30 billion.
CI
KoBioLabs,Inc has filed an IPO.
CI
KoBioLabs, Inc announced that it has received KRW 4 billion in funding from CJ Cheiljedang Corporation
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A348150 Stock
  4. News KoBioLabs, Inc